Growth Metrics

Journey Medical (DERM) Gross Profit (2020 - 2026)

Journey Medical filings provide 6 years of Gross Profit readings, the most recent being $10.0 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 26.2% to $10.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $39.7 million, a 15.93% increase, with the full-year FY2025 number at $40.3 million, up 17.69% from a year prior.
  • Gross Profit hit $10.0 million in Q4 2025 for Journey Medical, down from $11.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $15.1 million in Q1 2022 to a low of $5.6 million in Q4 2022.
  • Median Gross Profit over the past 5 years was $8.9 million (2022), compared with a mean of $9.1 million.
  • The widest YoY moves for Gross Profit: up 133.39% in 2023, down 62.13% in 2023.
  • Journey Medical's Gross Profit stood at $8.0 million in 2021, then plummeted by 30.26% to $5.6 million in 2022, then surged by 133.39% to $13.0 million in 2023, then crashed by 38.97% to $7.9 million in 2024, then rose by 26.2% to $10.0 million in 2025.
  • The last three reported values for Gross Profit were $10.0 million (Q4 2025), $11.3 million (Q3 2025), and $10.1 million (Q2 2025) per Business Quant data.